Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

390 Press Releases
DateTitleCompany
09 Nov 15 Teva Announces Breakthrough Therapy Designation for SD-809 Granted by FDA for the Treatment of Tardive Dyskinesia Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Oct 15 Teva to Host Third Quarter 2015 Financial Results Conference Call and Webcast on October 29, 2015 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Oct 15 Teva Announces Exclusive Launch of Generic Avodart® Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Oct 15 Teva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of Relapsing-Remitting Multiple Sclerosis Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Oct 15 Teva Reinforces Focus on Advancing Multiple Sclerosis Treatment at 31st ECTRIMS Congress Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Oct 15 Teva Accelerates its Emerging Markets Growth Strategy with the Acquisition of Rimsa, a Leading Independent Pharmaceutical Company in Mexico with a Portfolio of Products and Patents in Latin America Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Sep 15 Important New Data from Teva's TEV-48125 Phase 2B Migraine Program Published in Lancet Neurology in Back-to-Back Articles Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Sep 15 Teva Announces Approval of COPAXONE® in Japan for the Prevention of Relapse of Multiple Sclerosis Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 Sep 15 Teva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Sep 15 Teva Reinforces Leadership Position in Respiratory with Acquisition of Gecko Health Innovations Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Sep 15 Teva Announces FDA Acceptance of a Supplemental New Drug Application for ProAir® RespiClick (albuterol sulfate) Inhalation Powder for Pediatric Patients Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Sep 15 Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Sep 15 Teva Introduces “Design for Dialogue” to Support Patient-Doctor Conversations on Responsible Pain Management Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Sep 15 Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic transdermal system), First and Only Transdermal Patch System for the Acute Treatment of Migraine Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Aug 15 Teva Announces FDA Acceptance of NDA for SD-809 for Treatment in Huntington Disease Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Aug 15 Teva and Immuneering Announce Teva’s Purchase of 51% Equity Share of Genomic-Analysis Company Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 Jul 15 Teva Secures $33.75 Billion Financing Commitment Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Jul 15 Teva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorization Application Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Jul 15 Teva Issues Statement Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Jul 15 Teva First to Receive Approval and Launch Generic Axert® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Jul 15 Teva and Xenon Provide Update on TV-45070 Phase 2b Study in Osteoarthritis Pain Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Jul 15 Teva Launches Generic Aggrenox® Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 Jul 15 Teva Withdraws Proposal to Acquire Mylan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 Jul 15 Teva Reports Preliminary Second Quarter 2015 Results Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
21 Jul 15 Teva to Report Second Quarter 2015 Financial Results on July 30, 2015 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Jul 15 Teva Launches Educational Initiative to Arm Women with Facts about Emergency Contraception Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Jun 15 Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Jun 15 Teva and Microchips Biotech Announce Partnership to Enhance Patient Outcomes through Digital Drug Delivery Technology Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Jun 15 Teva to Present New Findings at the American Headache Society (AHS) Meeting – Analysis of Migraine Phase IIb Studies Provides Novel Insights into TEV-48125 Efficacy and Safety in Both Episodic & Chronic Migraine Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
19 Jun 15 Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V. Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.